← Leaderboards
Ronald Postuma
Washington University
$606,572
Attributed
$606,572
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $7.9M · FY2021–25$10M$7.5M$5M$2.5M$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,409,385 · 3
By mechanism
U19$29,409,385 · 3
Top collaborators
- Bradley F Boeve4 shared
- Yo-El S Ju4 shared
Most similar at Washington University
Same institution · by research overlap
- John Morris$91,785,862
- Howard J Edenberg$27,305,449
- Ernesto Bernal-Mizrachi$11,762,416
- James B Skeath$26,614,879
- Christopher F Basler$44,557,002
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposS Disease Related DementiaDiagnosisPreventSamplingS DiseaseLewy Body DementiaEarly InterventionNeuroimagingPhenotypeRecommendationRem Sleep Behavior DisorderBiological MarkersScanningProspectiveClinical TrialsCohortBloodNappingNeurodegenerative DisordersParkinson DiseaseParticipantAmericanStandardization
Grant awards (8)
North American Prodromal Synucleinopathy Consortium for RBD, Stage 2 (NAPS2)$6,952,731
U19 · FY2025 · AG
Project: Predicting Phenoconversion$132,424
U19 · FY2025 · AG · contact PI
North American Prodromal Synucleinopathy Consortium for RBD, Stage 2 (NAPS2)$7,100,969
U19 · FY2023 · AG
Project: Predicting Phenoconversion$147,132
U19 · FY2023 · AG · contact PI
North American Prodromal Synucleinopathy Consortium for RBD, Stage 2 (NAPS2)$7,016,272
U19 · FY2022 · AG
Project: Predicting Phenoconversion$151,849
U19 · FY2022 · AG · contact PI
North American Prodromal Synucleinopathy Consortium for RBD, Stage 2 (NAPS2)$7,732,841
U19 · FY2021 · AG
Project: Predicting Phenoconversion$175,167
U19 · FY2021 · AG · contact PI